Literature DB >> 1723077

Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides.

M P Landini1, A Ripalti, K Sra, P Pouletty.   

Abstract

In the present study, several peptides of the major structural antigen (pp150) of human cytomegalovirus (CMV) have been chemically synthesized and tested by a modified slot blotting procedure for their ability to bind CMV-specific immunoglobulin G (IgG) and IgM present in human sera. The sequences of the peptides were deduced on the basis of either (i) their presence in a fusion protein already known to be frequently recognized by human antibody or (ii) their high content of hydrophilic amino acids as deduced from the published nucleotide sequence. An important IgM-binding epitope was found to be located in the last 38 amino acids at the carboxy terminus of the molecule. This region reacts with anti-CMV IgM present in the great majority (83.3%) of IgM-positive human sera, and adsorption experiments have shown that IgM titers to the entire pp150 decrease 25 to 50% in most sera previously absorbed with this region. The overall results obtained endorse the continued synthesis of other sequences in order to define a group of peptides sensitive and specific enough to replace the virus and infected cells as an antigenic substrate in the serological evaluation of anti-CMV antibody.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723077      PMCID: PMC270226          DOI: 10.1128/jcm.29.9.1868-1872.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Human cytomegalovirus proteins.

Authors:  M P Landini; S Michelson
Journal:  Prog Med Virol       Date:  1988

2.  Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection.

Authors:  M P Landini; G Mirolo; P Coppolecchia; M C Re; M La Placa
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

3.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

4.  The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties.

Authors:  G Jahn; B C Scholl; B Traupe; B Fleckenstein
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

5.  Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus.

Authors:  G Jahn; T Kouzarides; M Mach; B C Scholl; B Plachter; B Traupe; E Preddie; S C Satchwell; B Fleckenstein; B G Barrell
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

6.  A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia.

Authors:  J Dillner; L Dillner; J Robb; J Willems; I Jones; W Lancaster; R Smith; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

8.  Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis.

Authors:  A Ripalti; M P Landini; E S Mocarski; M La Placa
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

9.  Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

Authors:  M P Landini; T Lazzarotto; A Ripalti; M X Guan; M La Placa
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

10.  Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.

Authors:  R S Smith; R B Naso; J Rosen; A Whalley; Y L Hom; K Hoey; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

View more
  7 in total

1.  Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.

Authors:  K D Greis; W Gibson; G W Hart
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

2.  Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.

Authors:  V A Sundqvist; W Xu; B Wahren
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

3.  Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.

Authors:  A E Greijer; J M van de Crommert; S J Stevens; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens.

Authors:  R Vornhagen; B Plachter; W Hinderer; T H The; J Van Zanten; L Matter; C A Schmidt; H H Sonneborn; G Jahn
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

5.  Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay.

Authors:  M P Landini; T Lazzarotto; G T Maine; A Ripalti; R Flanders
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

6.  Construction of polyepitope fusion antigens of human cytomegalovirus ppUL32: reactivity with human antibodies.

Authors:  A Ripalti; Q Ruan; M C Boccuni; F Campanini; G Bergamini; M P Landini
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

Review 7.  Disordered epitopes as peptide vaccines.

Authors:  Christopher A MacRaild; Jeffrey Seow; Sreedam C Das; Raymond S Norton
Journal:  Pept Sci (Hoboken)       Date:  2018-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.